ITOS
Iteos Therapeutics, Inc.
CEO Michel Detheux sold $498K of Iteos Therapeutics, Inc.
Sold$497,905
$34.34Price
14,500Shares
−29%Stake
What ITOS did after the filing
- The stock from Thu, Feb 24 close, $35.81
- −3.5%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Apr 7 close.
Traded Wed, Feb 23. Filed Thu, Feb 24, 3:00 PM ET, during the session. Returns use the Feb 24 close and the Apr 7 close. Not investment advice.